December, 11, 2025 1:00 PM MST
Multi-omics dissection of the molecular and pharmacological effects of inhaled cannabis
Professor Carolyn Baglole earned her Bachelor of Science and Master of Science degrees from the University of Prince Edward Island, followed by a PhD in Physiology and Pharmacology from the University of Calgary. Dr. Baglole then completed postdoctoral training at the University of Rochester in the Department of Environmental Medicine, where she deepened her expertise in pulmonary biology and environmental health. Since joining McGill University in 2010, Dr. Baglole has established herself as a leading researcher in the field of lung disease and inflammation, with a growing focus on the biological effects of cannabis. She served as the inaugural Director of the McGill Research Centre for Cannabis, where she led interdisciplinary efforts to advance scientific understanding of cannabis and its impact on health and society. She has authored more than 100 peer-reviewed publications in high-impact journals including FASEB Journal, American Journal of Physiology – Lung Cellular and Molecular Physiology, and Journal of Cellular Physiology. Her research is supported by major Canadian funding agencies such as the Canadian Institutes of Health Research (CIHR) and the Natural Sciences and Engineering Research Council of Canada (NSERC). In addition to her research and leadership roles, Dr. Baglole serves on several editorial boards and government advisory panels, contributing her expertise to guide policy and scientific discourse around cannabis, tobacco and vaping.